Trial NCT04895410

View at ClinicalTrials.gov 
Org. Study IDs: M20-917
Secondary IDs: 2021-001067-24

Last trial update was posted on 2023-03-06

MeSH Interventions

Daratumumab Dexamethasone Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Strategic considerations

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID